Maxigesic® IV Phase 3 Exposure Study

Clinical trial NCT04005755 · COMPLETED

Trial details

NCT number: NCT04005755
Sponsor: AFT Pharmaceuticals, Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Postoperative Pain

Start date: 2019-07-22
Primary completion: 2020-06-30
Enrollment: 232

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.